| WOMAC Pain Scores | ||||
---|---|---|---|---|---|
 | Time scale | Treatments | |||
Study |  | Corticosteroid (CS) 3 ml | CS (3 ml) + (6 ml) saline | ||
Young et al (110 patients) [45] | Pain (Baseline) | 12.2 | 12.3 | ||
 | Pain (3 months) | 8.8 | 8.9 | ||
 |  | CS | Placebo | ||
 |  | Mean, (SD), N | Mean, (SD), N | ||
Paskins et al. (199 patients) [46] | Pain (Baseline) | 10.7 ± 4.0, 66 | 10.7 ± 2.8, 66 | ||
 | Pain (2 months) | 7.0 (4.3), 61 | 8.7 (4.1), 62 | ||
 | Pain (4 months) | 7.9 (4.3), 59 | 9.1 (4.1), 59 | ||
 | Pain (6 months) | 8.8 (4.3), 56 | 9.1 (4.1), 60 | ||
 |  | CS | Placebo | ||
Lambert et al. (52 patients) [48] | Pain (Baseline) | 310.1 ± 54.6 mm | 314.3 ± 76.2 | ||
 | Pain (1 month) | 149.6 ± 113 mm | 276.4 ± 129.0 | ||
 | Pain (2 months) | 157.4 ± 127.2 mm | 306.5 ± 121.2 | ||
 |  | CS | Hyaluronic Acid | ||
Spitzer et al. (312 patients) [52] | Pain (Baseline) | 64.53 ± 0.98 | 63.40 ± 1.00 | ||
 | Pain (1 month) | 35.04 ± 1.91 | 45.5 ± 1.97 | ||
 | Pain (6 months) | 48.47 ± 2.47 | 44.03 ± 2.48 | ||
 |  | Group 0—CS | Group 1—CS + HA | Group 2—CS + HA | Group 3—CS + HA |
De Rezende et al. (82 patients) [50] | Pain (Baseline) | 11.1 (3.3) | 10.4 (3.3) | 10.5 (4.9) | 10.5 (4.4) |
 | Pain (1 months) | 6.6 (5.4) | 6.0 (3.9) | 6.9 (5.2) | 6.8 (4.4) |
 | Pain (3 months) | 7.1(4.2) | 7.9 (3.3) | 7.4 (4.4) | 7.0 (5.0) |
 | Pain (6 months) | 6.9 (4.6) | 8.0 (4.7) | 6.4 (4.9) | 7.9 (4.7) |
 | Pain (12 months) | 6.4 (4.1) | 7.7 (4.8) | 8.0 (5.2) | 7.6 (4.7) |